Refresher Course: Head and Neck

RC 1208 - Contemporary imaging topics in head and neck cancer

February 28, 08:00 - 09:00 CET

5 min
Chairperson's introduction
Burce Özgen Mocan, Chicago / United States
15 min
Imaging considerations in HPV-associated oropharyngeal cancer
Franca Wagner, Bern / Switzerland
  1. To understand the distinct clinical phenotype of HPV-related oropharyngeal cancer (HPVOPC) and its impact on management strategies.
  2. To gain an appreciation of the differing staging implications related to HPV with reference to the 8th AJCC.
  3. To become familiar with the characteristic imaging appearances of HPVOPC on MRI and CT and the role of advanced MRI studies in diagnosis and monitoring.
15 min
The role of quantitative diffusion imaging in head and neck cancer
Ann Dorothy King, Hong Kong / China
  1. To discuss how the acquisition and analysis of diffusion-weighted imaging (DWI) sequences can be optimised for quantification.
  2. To describe the potential diagnostic, prognostic and monitoring role of quantitative DWI in head and neck cancer.
  3. To outline the current evidence for the added value of quantitative DWI in head and neck cancer.
15 min
FDG18-PET-CT versus MRI for the early follow-up of the post-chemo-radiotherapy neck: pros and cons
Anne Renée Juliette Péporté, Frauenfeld / Switzerland
  1. To understand the advantages and disadvantages of FDG18-PET-CT and MRI in the assessment of the post-chemo-radiotherapy neck.
  2. To reflect on the optimal timing of early post-treatment studies with each imaging modality.
  3. To become familiar with the imaging appearances of recurrent or residual disease mimics with FDG18-PET-CT and MRI.
10 min
Panel discussion: Which are the most useful imaging biomarkers in head and neck cancer?